Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 82

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 85
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
close
Save to Existing Project
Save to a New Project
New, Innovative CNS Drug Sought At End of Phase III Trial Level
Leiras Takeda Pharmaceuticals Finland flag Finland
Abstract ID:
New innovative drug to be used in some CNS-areas, primarily to support a product indicated for schizophrenia...
Contact
Participants
You
Email me a copy of this message

New innovative drug to be used in some CNS-areas, primarily to support a product indicated for schizophrenia.

Type of Business Relationship Sought

The clinical trials should have been mainly performed and there shouldn´t be a need for Takeda to make co-funding or co-development for the project.

FEATURED
Last Updated Sep 2014
Technology Type
Phase of Development CLINICAL TRIALS
CORPORATION